Cyclin D1 expression is useful as a prognostic indicator for advanced esophageal carcinomas, but not for superficial tumors

Digestive Diseases and Sciences

Volumn 45, Issue 5, 2000, Pages 864-869

  Toyoda, Hideki ^a,b   Nakamura, Tsuneya ^a,b   Shinoda, Masayuki ^a,b   Suzuki, Takashi ^a,b   Hatooka, Shunzo ^a,b   Kobayashi, Seibi ^a,b   Ohashi, Kazuhiko ^a,b   Seto, Masao ^a,b   Shiku, Hiroshi ^a,b   Nakamura, Shigeo ^a,b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclin D1; Esophageal carcinoma; Prognostic factor

Indexed keywords

CYCLIN D1;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SUPERFICIAL CANCER; SURVIVAL RATE;

CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CARCINOSARCOMA; CYCLIN D1; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034005548     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005552419905     Document Type: Article

References (30)

1. 1. Endo M, Takeshita K, Yoshida M: How can we diagnose the early stage of esophageal cancer? Endoscopic diagnosis. Endoscopy 18:11-18, 1986
2. 2. Yosinaka H, Shimizu H, Fukumoto T, Baba M: Superficial esophageal carcinoma: A clinicopathological review of 59 cases. Am J Gastroenterol 86:1413-1418, 1991
3. 3. Nishimaki T, Tanaka O, Suzuki T, Aizawa K, Watanabe H, Muto T: Tumor spread in superficial esophageal cancer: Histopathologic basis for rational surgical treatment. World J Surg 17:766-772, 1993
4. 4. Kato H, Tachimori Y, Watanabe H: Superficial esophageal carcinoma: Surgical treatment and the results. Cancer 66:2319-2323, 1990
5. 5. Peracchia A, Roul A, Bonvina L, Bardini R, Segalin A, Castro C, Cavazzini F, Tremolada C: Early squamous cell carcinoma of the esophagus: Diagnosis and management. Dig Surg 6:109-113, 1989
6. 6. Lammie G, Peters G: Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3:413-420, 1991
7. 7. Jiang W, Kahn SM, Tomita N, Zhang Y-J, Lu SH, Weinstein B: Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 52:2980-2983, 1992
8. 8. Bukley MF, Sweeney KJE, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127-2133, 1993
9. 9. Schuuring E, Verhoeven E, Litvinov S, Michalides RJAM: The product of the EMSI gene, amplified and overexpressed in human carcinomas, is homogeneous to a v-src substrate and is located in cell-substratum contact site. Mol Cell Biol 13:2891-2898, 1993
10. 10. Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, Dickson C, Arnold A, Peters G: DII5287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6:439-444, 1991
11. 11. Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, Arnold A: Rearrangement and overexpression of DIIS287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 6:449-453, 1991
12. 12. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A: A novel cyclin encoded by a bcl-1 linked candidate oncogene. Nature 350:512-515, 1991
13. 13. Withers DA, Harvey RC, Faust JB, Melnky O, Carey K, Mecker TC: Characterization of a candidate bcl-1 gene. Mol Cell Biol 11:4846-4853, 1991
14. 14. Hunter T, Pines J: Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573-582, 1994
15. 15. Zhou P, Jiang W, Zhang Y-J, Kahn SM, Schieren I, Santella RM, Weinstein IB: Antisense to cyclin D1 inhibits growth and reverse the transformed phenotype of human esophageal cancer cells. Oncogene 11:571-580, 1995
16. 16. Kitagawa Y, Ueda M, Ando N, Shinozawa Y, Shimizu N, Abe O: Significance of int-2/bst-1 coamplification as a prognostic factor in patients with esophageal squamous cell carcinoma. Cancer Res 51:1504-1508, 1991
17. 17. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T: Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 146:1161-1169, 1995
18. 18. Banno S, Yoshikawa K, Nakamura S, Yamamoto K, Seito T, Nitta M, Takahashi T, Ueda R, Seto M: Monoclonal antibody against PRADI/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus. Jpn J Cancer Res 85:918-926, 1994
19. 19. Kuroda H, Komatsu H, Nakamura S, Niitsu Y, Takahashi T, Ueda R, Seto M: The positive nuclear staining observed with monoclonal antibody against PRADI/cyclin D1 correlates with mRNA expression in mantle cell lymphoma. Jpn J Cancer Res 86:890-898, 1995
20. 20. Watanabe H, Jass JR, Sobin LH, in collaboration with pathologists in eight countries: Definition and explanatory notes. In World Health Organization International Histological and Gasteric Tumors, 2nd ed. Berlin, Springer-Verlag, 1990, pp 11-18
21. 21. International Union Against Cancer (UICC): TNM Classification of Malignant Tumors, 4th ed. Berlin, Springer-Verlag, 1987
22. 22. Jiang W, Zhang Y-J, Kahn SM, Hollstein MC, Santella RM, Lu SH, Harris CC, Montesano R, Weinstein IB: Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 90:9026-9030, 1993
23. 23. Tsuruta H, Sakamoto H, Onda M, Terada M: Amplification and overexpression of EXP1 and EXP2/cyclin D1 genes in human esophageal carcinomas. Biochem Biophys Res Commun 196:1529-1536, 1993
24. 24. Gramlich TL, Fritsch CR, Maurer D, Eberle M, Gansler TS: Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma. Diagn Mol Pathol 3:255-259, 1994
25. 25. Shinozaki H, Ozawa S, Ando N, Tsuruta H, Terada M, Ueda M, Kitajima M: Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res 2:1155-1161, 1996
26. 26. Jiang W, Kahn SM, Zhou P, Zhang Y-J, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB: Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8:3447-3457, 1993
27. 27. Lovec H, Sewing A, Lucibello FC, Muller R, Moroy T: Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: Link between cell cycle control and malignant transformation. Oncogene 9:323-326, 1994
28. 28. Hinds HW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA: Function of human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91:709-713, 1994
29. 29. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM: Cyclin D1 transgene impedes lymphocyte mutation and collaborates in lymphomagenesis with the myc gene. EMBO J 3:255-259, 1994
30. 30. Hirama T, Koeffler P: Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841-854, 1995